article thumbnail

STAT+: ‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices

STAT

In 1997, Celgene obtained a key patent for what would become a blockbuster blood cancer treatment, giving it a monopoly until 2019. Not long after the patent was awarded, the company leveraged federally funded research and began investigating different forms of the compound, called Revlimid.

article thumbnail

Extemporaneous Compounding

RX Note

Introduction In 2018, the Ministry of Health Malaysia published the Good Compounding Practice as a guidance for compounding practices. NOTE: When compounding a preparation using the contents of an ampoule , care should be taken to withdraw the solution using a filter needle to avoid incorporating glass particles into the compound.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

China leads APAC in institute-led clinical trials: GlobalData

Express Pharma

According to GlobalData’s Pharmaceutical Intelligence Center, the number of single-country, interventional trials conducted by institutes has surged at a compound annual growth rate of 28 per cent from 656 in 2019 to 2,290 in 2023 across the major APAC countries. Notably, Phase II trials surged from 223 to 889.

article thumbnail

Boehringer backs AI-powered anti-infective startup ArrePath

pharmaphorum

The Princeton, New Jersey-based startup will use the funding to develop its artificial intelligence and imaging based drug discovery platform, used to identify compounds with new and under-exploited mechanisms of action. million deaths a year, according to the 2019 Gram Report. Dr Zemer Gitai.

article thumbnail

Key vaccine adjuvant biosynthesised

European Pharmaceutical Review

It is a key component of human vaccines for shingles, malaria, coronavirus disease 2019 and others under development.” Bioengineering vaccine adjuvants The paper explained: “QS-21 is a potent vaccine adjuvant currently sourced by extraction from the Chilean soapbark tree. Martin et al. Martin et al.

article thumbnail

Beckley Psytech raises $80m for psychedelic meds development

pharmaphorum

The Oxford-based company had originally hoped to raise $50 million from the series B, and the scale of the financing is further evidence that repurposing psychedelic compounds as potential therapies for neuro-psychiatric disorders is a hot topic in biopharma. Beckley – formerly known as Beckley Canopy Therapeutics – raised £7.4

article thumbnail

STAT+: Pharmalittle: WHO pandemic accord may force pharma to disclose prices; FDA OKs first therapy to delay type 1 diabetes

STAT

As of 2019, about 1.9 The agency issued 62 warning letters and 23 import alerts related to drugs, excluding compound-related actions. The monoclonal antibody teplizumab, which will be marketed under the brand name Tzield and is from ProventionBio and Sanofi, is given through intravenous infusion.

Diabetes 177